Ki-67 expression in patients with uterine leiomyomas, uterine smooth muscle tumors of uncertain malignant potential (STUMP) and uterine leiomyosarcomas (LMS)

Acta Obstetricia et Gynecologica Scandinavica

Volumn 83, Issue 11, 2004, Pages 1085-1088

  Mayerhofer, Klaus ^a   Lozanov, Plamen ^a   Bodner, Klaus ^a   Bodner Adler, Barbara ^a   Kimberger, Oliver ^a   Czerwenka, Klaus ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Ki 67; Leiomyosarcoma; STUMP; Uterine leiomyoma

Indexed keywords

ANTHRACYCLINE DERIVATIVE; KI 67 ANTIGEN;

ACCURACY; ANTIGEN EXPRESSION; ARTICLE; BRACHYTHERAPY; CANCER SURVIVAL; COBALT TELETHERAPY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; HYSTERECTOMY; IMMUNOHISTOCHEMISTRY; LEIOMYOSARCOMA; MAJOR CLINICAL STUDY; MUSCLE TUMOR; MYOMETRIUM; PRIORITY JOURNAL; SALPINGOOOPHORECTOMY; UTERUS MYOMA;

ADULT; AGED; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; LEIOMYOMA; LEIOMYOSARCOMA; MIDDLE AGED; NEOPLASMS, MUSCLE TISSUE; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; SMOOTH MUSCLE TUMOR; TUMOR MARKERS, BIOLOGICAL; UTERINE NEOPLASMS;

EID: 7644225634     PISSN: 00016349     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0001-6349.2004.00502.x     Document Type: Article

References (19)

1. Zhai Y-L, Nikaido T, Toki T, Shiozwawa A, Orii A, Fujii S. Prognostic significance of bcl-2 expression in leiomyosarcoma of the uterus. Br J Cancer 1999; 80: 1658-64.
2. Mittal K, Demopoulos RI. MIB-1 (KI-67), p53, estrogen receptor, and progesterone receptor expression in uterine smooth muscle tumors. Human Pathol 2001; 32: 984-7.
3. Clement PB. The pathology of uterine smooth muscle tumors and mixed endometrial stromal smooth muscle tumors: a selective review with emphasis on recent advances. Int J Gynecol Pathol 2000; 19: 39-55.
4. Zaloudek CJ, Norris HJ. Mesenchymal tumors of the uterus. In: Kurman RJ, ed. Blaustein's Pathology of the Female Genital Tract. New York: Springer Verlag, 1994: 849-914.
5. Schwartz Z, Dgani R, Lancet M, Kessler I. Uterine sarcoma in Israel: a study 104 cases. Gynecol Oncol 1985; 20: 354-63.
6. Evans HL, Chawla SP, Simpson C, Finn KP. Smooth muscle neoplasms of the uterus other than ordinary leiomyoma. A study of 46 cases, with emphasis on diagnostic criteria and prognostic factors. Cancer 1988; 62: 2239-47.
7. Nordal RR, Kristensen GB, Kaern J, Stenwig AE, Pettersen EO, Trope CG. The prognostic significance of stage, tumor size, cellular atypia and DNA ploidy in uterine leiomyosarcoma. Acta Oncol 1995; 34: 797-802.
8. Cattoretti G, Becker MHG, Key G, Duchrow M, Schluter C, Galle J et al. Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave processed formalin-fixed paraffin sections. J Pathol 1992; 168: 357-63.
9. Layfield LJ, Liu K, Dodge R, Barsky SH. Uterine smooth muscle tumors: utility of classification by proliferation, ploidity, and prognostic markers versus traditional histopathology. Arch Pathol Lab Med 2000; 124: 221-7.
10. Chou CY, Huang SC, Tsai YC, Hsu KF, Huang KE. Uterine leiomyosarcoma has deregulated cell proliferation, but not increased microvessel density compared with uterine leiomyoma. Gynecol Oncol 1997; 65: 225-31.
11. Zhai YL, Nikaido T, Shizawa T, Orii A, Fujii S. Expressions of cyclins and cyclin-dependent kinases in smooth muscle tumors of the uterus. Int J Cancer 1999; 84: 244-50.
12. Zhai YL, Kobayashi Y, Mori A, Orii A, Nikaido T, Konishi I et al. Expression of steroid receptors, Ki-67, and p-53 in uterine leiomyosarcomas. Int J Gynecol Pathol 1999; 18: 20-8.
13. Amada S, Nakano H, Tsuneyoshi M. Leiomyosarcoma versus bizarre and cellular leiomyomas of the uterus: a comparative study based on the MIB-1 and proliferating cell nuclear antigen indices, p-53 expression, DNA flow cytometry, and muscle specific actins. Int J Gynecol Pathol 1995; 14: 134-42.
14. Bell SW, Kempson RL, Hendrickson MR. Problematic uterine smooth muscle neoplasms. A clinicopathological study of 213 cases. Am J Surg Pathol 1994; 18: 535-58.
15. Mayerhofer K, Obermair A, Windbichler G, Petru E, Kainder A, Heifer L et al. Leiomyosarcoma of the uterus: a clinicopathologic multicenter study of 71 cases. Gynecol Oncol 1999; 74: 196-201.
16. Seshadri R, Leong AS, McCaul K, Firgaira FA, Setlur V, Horsfall DJ. Relationship between p53 gene abnormalities and other tumor characteristics in breast cancer prognosis. Int J Cancer 1996; 69: 135-41.
17. Rudolph P, Olsson H, Bonatz G, Ratjen V, Boite H, Baldetorp B et al. Correlation between p53, c-erb B-2, and topoisomerase IIa expression, DNA ploidity, hormonal receptor status and proliferation in 356 node negative breast carcinomas: Prognostic implications. J Pathol 1999; 187: 207-16.
18. Dunton CJ, van Hoeven KH, Kovatich AJ, Oliver RE, Scacheri RQ, Cater JR et al. Ki-67 antigen staining as an adjunct to identifying cervical intraepithelial neoplasia. Gynecol Oncol 1997; 64: 451-5.
19. Jeffers MD, Oakes SJ, Richmond JA, Macaulay EM. Proliferation, ploidity and prognosis in uterine smooth muscle tumors. Histopathology 1996; 29: 217-23.